France Platelet Rich Plasma (prp) Market Size & Outlook
Related Markets
France platelet rich plasma (prp) market highlights
- The France platelet rich plasma (prp) market generated a revenue of USD 27.1 million in 2023 and is expected to reach USD 73.9 million by 2030.
- The France market is expected to grow at a CAGR of 15.4% from 2024 to 2030.
- In terms of segment, pure prp was the largest revenue generating type in 2023.
- Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.
Platelet rich plasma (prp) market data book summary
Market revenue in 2023 | USD 27.1 million |
Market revenue in 2030 | USD 73.9 million |
Growth rate | 15.4% (CAGR from 2023 to 2030) |
Largest segment | Pure prp |
Fastest growing segment | Leukocyte Rich PRP |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pure PRP, Leukocyte Rich PRP |
Key market players worldwide | Johnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences |
Other key industry trends
- In terms of revenue, France accounted for 4.2% of the global platelet rich plasma (prp) market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK platelet rich plasma (prp) market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 123.0 million by 2030.
Pure prp was the largest segment with a revenue share of 51.66% in 2023. Horizon Databook has segmented the France platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.
The French market for PRP therapy is witnessing a surge in growth opportunities driven by several key factors. There is a noticeable increase in chronic wounds and diabetic ulcers, a trend associated with the expanding aging population and the growing number of surgical procedures.
The prevalence of diabetes in France is of particular concern, standing at 8.6% according to 2021 data from the International Diabetes Federation, which translates to approximately 3,942,900 cases. This substantial diabetic population suggests a likelihood of a surge in diabetes-related ulcers and wounds.
As a result, the demand for PRP therapy in France, especially for diabetic foot ulcers, is expected to rise significantly. PRP has shown promise in enhancing wound healing, making it a valuable treatment option for healthcare providers.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Platelet Rich Plasma (PRP) Market Scope
Platelet Rich Plasma (PRP) Market Companies
Name | Profile | # Employees | HQ | Website |
---|---|---|---|---|
Celling Biosciences | View profile | - | - | |
APEX Biologix | View profile | 11-50 | Murray, Utah, United States, North America | https://apexbiologix.com |
Juventix Regenerative Medical | View profile | 11-50 | Tampa, Florida, United States, North America | https://juventix.com/ |
Dr. PRP USA | View profile | 11-50 | Stafford, Texas, United States, North America | https://www.drprpusa.com |
EmCyte Corporation | View profile | 11-50 | Fort Myers, Florida, United States, North America | https://emcyte.com/ |
Arthrex | View profile | 5001-10000 | Naples, Florida, United States, North America | https://www.arthrex.com/ |
Terumo Corp | View profile | 30207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | https://www.terumo.com |
Zimmer Biomet Holdings Inc | View profile | 18000 | 345 East Main Street, Warsaw, IN, United States, 46580 | https://www.zimmerbiomet.com |
Stryker Corp | View profile | 52000 | 1941 Stryker Way, Portage, MI, United States, 49002 | https://www.stryker.com |
Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
France platelet rich plasma (prp) market size, by type, 2018-2030 (US$M)
France Platelet Rich Plasma (PRP) Market Outlook Share, 2023 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more